quantisnow
FeedTopReportsPricing
⌘K
Live feed
11:43:23·709d
NEWSRelease
Biolase Inc. logo

Benchmark Reiterates Speculative Buy on Biolase, Maintains $0.4 Price Target

BIOL· Biolase Inc.
Health Care
Original source

Companies

  • BIOL
    Biolase Inc.
    Health Care

Related

  • PR149d
    BIOLASE Showcases Advanced YSGG Laser Solutions for Periodontal and Implant Care at GNYDM 2025
  • SEC562d
    SEC Form 8-K filed by Biolase Inc.
  • PR569d
    BIOLASE Voluntarily Initiates Chapter 11 Proceedings
  • SEC569d
    Biolase Inc. filed SEC Form 8-K: Bankruptcy or Receivership
  • SEC594d
    SEC Form 8-K filed by Biolase Inc.
  • SEC603d
    SEC Form 8-K filed by Biolase Inc.
  • SEC623d
    SEC Form 10-Q filed by Biolase Inc.
  • PR623d
    BIOLASE Reports 2024 Second Quarter Results; Achieves 40% Gross Margin as Global Consumable Sales Strengthen
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022